These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28377564)

  • 1. Treatment of hypertension: choosing the first‑line treatment. Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 1.
    Messerli FH; Jaeschke R
    Pol Arch Intern Med; 2017 Mar; 127(3):219-220. PubMed ID: 28377564
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hypertension: When to start? What is the target? Dr. Franz H. Messerli in an interview with Dr. Roman Jaeschke: part 2.
    Messerli FH; Jaeschke R
    Pol Arch Intern Med; 2017 Mar; 127(3):221-222. PubMed ID: 28377565
    [No Abstract]   [Full Text] [Related]  

  • 3. HOPE-‑3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke.
    Yusuf S; Panju A; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1033-1035. PubMed ID: 28010010
    [No Abstract]   [Full Text] [Related]  

  • 4. SPRINT trial and blood pressure treatment. Dr. Gordon Guyatt in an interview with Dr. Roman Jaeschke.
    Guyatt G; Jaeschke R
    Pol Arch Med Wewn; 2016 Oct; 126(10):806-807. PubMed ID: 27872460
    [No Abstract]   [Full Text] [Related]  

  • 5. ["Individualized antihypertensive therapy. Diuretics degraded as hypertension drugs (interview by Dr. med. Jochen Aumiller)].
    Düsing R
    MMW Fortschr Med; 2011 Dec; 153(51-52):21. PubMed ID: 22263286
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive therapy is successful as hardly any other]. Interview by Dr. rer. nat. S. Kressenstein].
    Middeke M
    Fortschr Med; 1998 Jun; 116(18-19):27-8. PubMed ID: 9691534
    [No Abstract]   [Full Text] [Related]  

  • 7. Franz H. Messerli, MD: a conversation with the editor. Interview by William Clifford Roberts.
    Messerli FH
    Am J Cardiol; 2005 Jul; 96(1):154-65. PubMed ID: 15979456
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differential therapy of hypertension becomes more specific. Interview by Dr. R.-G. Sommer].
    Unger T
    Fortschr Med; 1997 Aug; 115(24):42-3. PubMed ID: 9410822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Does lowering blood pressure also prevent stroke?. Interview by Dr. med. Monika Flasnoecker].
    Schrader J
    Fortschr Med; 1997 Feb; 115(5):49-50. PubMed ID: 9162719
    [No Abstract]   [Full Text] [Related]  

  • 10. [A therapeutically delicate duo. Hypertension and COPD (interview by Dr. med. Jochen Aumiller)].
    Trenkwalder P
    MMW Fortschr Med; 2005 May; 147(19):41-2. PubMed ID: 15940936
    [No Abstract]   [Full Text] [Related]  

  • 11. The next 10 years in antihypertensive treatment. Interview by Tanya Stezhka.
    Cooper-Dehoff RM
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):669-71. PubMed ID: 23750675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiome: the beginning of understanding. Dr. Paul Moayyedi in an interview with Dr. Roman Jaeschke: part 1.
    Moayyedi P; Jaeschke R
    Pol Arch Intern Med; 2017 Feb; 127(2):135-136. PubMed ID: 28267141
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of asthma: predicting the future of atopic disease treatment Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 2.
    O'Byrne P; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1031-1032. PubMed ID: 28010009
    [No Abstract]   [Full Text] [Related]  

  • 14. [Beta blockers no longer the first choice in Great Britain. Treating hypertensive patients differently? (interview by Dr. Judith Neumeier)].
    Düsing R
    MMW Fortschr Med; 2006 Oct; 148(43):15. PubMed ID: 17619415
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of asthma: roles of different classes of drugs Dr. Paul O'Byrne in an interview with Dr. Roman Jaeschke: part 1.
    O'Byrne P; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1028-1030. PubMed ID: 28010008
    [No Abstract]   [Full Text] [Related]  

  • 16. BRIDGE trial. Dr. James Douketis in an interview with Dr. Roman Jaeschke: part 1.
    Douketis J; Jaeschke R
    Pol Arch Med Wewn; 2016 Oct; 126(10):798-800. PubMed ID: 27872457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium antagonists have a favorable long-term effect on lipid metabolism. Dr. K. P. Pollack presents results of his studies. Interview by Christine Schaefer].
    Pollack KP
    Fortschr Med; 1992 Nov; 110(32):64-5. PubMed ID: 1478601
    [No Abstract]   [Full Text] [Related]  

  • 18. VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3.
    Crowther M; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1026-1027. PubMed ID: 28010007
    [No Abstract]   [Full Text] [Related]  

  • 19. [Can low blood pressure also have risks? (interview by Dr. med. Jochen Aumiller)].
    Kolloch R
    MMW Fortschr Med; 2004 Apr; 146(16):18. PubMed ID: 15222495
    [No Abstract]   [Full Text] [Related]  

  • 20. 2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1.
    Crowther M; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1024. PubMed ID: 28010005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.